AzTrials
AzTrials

Adnexal Benign PathologyNCT02625025

Low vs Standard Pneumoperitoneum Pressure During Single Port Access Laparoscopic for Adnexal Pathology

A study testing Low pression pneumoperitoneum, Standard Pression Pneumoperitoneum and Single Port Access Laparoscopy in people with Adnexal Benign Pathology, run by University of Cagliari.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

During laparoscopy pneumoperitoneum creates the necessary space in which to perform the operation. Growing evidence in general surgery has shown that reduction of intra-abdominal pressure during laparoscopy is related to improved postoperative outcomes, decreased pain perception, length of hospital stay, and analgesic… Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Adnexal Benign Pathology
What is being tested?
Low pression pneumoperitoneum, Standard Pression Pneumoperitoneum and Single Port Access Laparoscopy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Jan 2016to Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • patients 18- 45 years old
  • elective laparoscopic operation
  • informed consent

Who cannot join

  • BMI > 30 kg/cm2
  • pregnancy
  • converting to laparotomy
  • malignant disease
  • unable or unwilling to give written consent

About this study

During laparoscopy pneumoperitoneum creates the necessary space in which to perform the operation. Growing evidence in general surgery has shown that reduction of intra-abdominal pressure during laparoscopy is related to improved postoperative outcomes, decreased pain perception, length of hospital stay, and analgesic rescue dosage in patients undergoing minimally invasive procedures using low pneumoperitoneum pressure (LPP) compared with standard pneumoperitoneum pressure (SPP). Aim of the study is to demonstrate the safety and feasibility of LPP during performance of Single Port Access Laparoscopy for benign adnexal pathologies.

Being tested
Low pression pneumoperitoneum, Standard Pression Pneumoperitoneum, Single Port Access Laparoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low pression pneumoperitoneumProcedure or surgery

    Pneumoperitoneum will be obtained by infusing carbon dioxide to distend the peritoneal cavity.

    Intra-abdominal pressure will be maintained at 8 mm Hg during pneumoperitoneum creation and insertion of trocars.

  • Standard Pression PneumoperitoneumProcedure or surgery

    Pneumoperitoneum will be obtained by infusing carbon dioxide to distend the peritoneal cavity.

    Intra-abdominal pressure will be maintained at 12 mm Hg during pneumoperitoneum creation and insertion of trocars.

  • Single Port Access LaparoscopyProcedure or surgery

    Laparoscopy surgery with use of only one incision of 2 cm in the umbilicus in order to threat benign adnexal pathology

Study groups in NCT02625025
Study groupRoleWhat they receive
Low pression pneumoperitoneumExperimentalPatients undergoing Single Port Access Laparoscopy for benign adnexal pathology with use of Low Pression Pneumoperitoneum (8 mm Hg)
Receives: Procedure: Low pression pneumoperitoneum; Procedure: Single Port Access Laparoscopy
Standard pression pneumoperitoneumExperimentalPatients undergoing Single Port Access Laparoscopy for benign adnexal pathology with use of Standard Pression Pneumoperitoneum (12 mm Hg)
Receives: Procedure: Standard Pression Pneumoperitoneum; Procedure: Single Port Access Laparoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain measured on a VAS scale

    Experienced pain over the last six hours measured on a VAS scale

    Measured: 6 hours

Secondary outcomes (5)
  1. Operation time

    Operating time in minutes.

    Measured: 0 hours after the operation

  2. Blood loss in ml

    Estimated blood loss in ml.

    Measured: 0 hours after the operation

  3. Complications

    Complications during surgery and late complications.

    Measured: Two months

  4. Shoulder tip pain measured on a VAS scale

    Experienced shoulder tip pain over the last 24 hours measured on a VAS scale.

    Measured: 24 hours

  5. Postoperative pain measured on a VAS scale

    Experienced pain over the last 24 hours measured on a VAS scale.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2015 (estimated)
  2. Study startJan 2016
  3. Primary completionOct 2017 (estimated)
  4. Study completionJan 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02625025
Sponsor's protocol ID
SPALPression
Status last verified
Dec 2015
First submitted
4 Dec 2015
Last updated
9 Dec 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Low pression pneumoperitoneum, Standard Pression Pneumoperitoneum and Single Port Access Laparoscopy in people with Adnexal Benign Pathology, run by University of Cagliari.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain measured on a VAS scale (time frame: 6 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in